OTHER INFORMATION
(Unaudited) (continued)
Quarterly Portfolio Schedules Information
The Trust files its complete schedule of portfolio holdings with the SEC for the first and third quarters of each fiscal year on Form N-Q; which are available on the SEC’s website at http://www.sec.gov. The Funds’ Forms N-Q may be reviewed and copied at the SEC’s Public Reference Room in Washington, DC, and that information on the operation of the Public Reference Room may be obtained by calling 1-800-SEC-0330. Copies of the portfolio holdings are also available to shareholders, without charge and upon request, by calling 1-800-820-0888.
Rydex Investments Board Review and Approval of the Investment Advisory Agreement
The Investment Company Act of 1940 (the “1940 Act”) requires that the initial approval of, as well as the continuation of, a fund’s investment advisory agreement (including all sub-advisory agreements) be specifically approved (1) by the vote of the trustees or by a vote of the shareholders of the fund, and (2) by the vote of a majority of the trustees who are not parties to the investment advisory agreement (or sub-advisory agreement) or “interested persons” of any party (the “Independent Trustees”), cast in person at a meeting called for the purpose of voting on such approval. In connection with such approvals, the fund’s trustees must request and evaluate, and the investment adviser (or sub-adviser) is required to furnish, such information as may be reasonably necessary to evaluate the terms of the advisory agreement (or sub-advisory agreement). In addition, the U.S. Securities and Exchange Commission (the “SEC”) takes the position that, as part of their fiduciary duties with respect to fund fees, fund boards are required to evaluate the material factors applicable to a decision to approve (or renew) an investment advisory agreement (or sub-advisory agreement).
Consistent with these responsibilities, the Rydex Series Funds’ Board of Trustees (the “Trust” and the “Board,” respectively) generally calls and holds one meeting each year that is dedicated to considering whether to renew the investment advisory agreements between the Trust and PADCO Advisors, Inc., which does business under the name Rydex Investments (“Rydex Investments” or the “Adviser”), with respect to existing funds in the Trust, including the funds discussed in this Annual Report (each a “Fund” and collectively, the “Funds”). The Board may also meet, from time to time, for the purpose of considering the initial approval of investment advisory agreements (or sub-advisory agreements), pursuant to which the Adviser (or sub-adviser) will provide investment advisory services to new or existing series of the Trust.
In preparation for these meetings, the Board requests and reviews a wide variety of materials provided by the Adviser (or applicable sub-adviser), including information about the Adviser’s (or sub-adviser’s) affiliates, personnel and operations. The Board also receives data provided by third parties. For existing Funds, this information is in addition to the detailed information about the Funds that the Board reviews during the course of each year, including information that relates to Fund operations and performance. The Board also receives a memorandum from Fund counsel regarding the responsibilities of the Board for the approval of each investment advisory agreement (or sub-advisory agreement). In addition, the Independent Trustees receive advice from independent counsel to the Independent Trustees, meet in executive session outside the presence of fund management, and participate in question and answer sessions with representatives of the Adviser (or sub-adviser).
For the Trust’s fiscal year ended March 31, 2009, the following investment advisory (or sub-advisory) agreements were in effect and therefore, subject to Board oversight and approval (or renewal), as necessary.
Investment Advisory Agreements for All Funds, Except the Alternative Strategies Allocation Fund and Global 130/30 Strategy Fund (Formerly, the Multi-Cap Core Equity Fund)
The investment advisory agreements dated January 18, 2008 between the Trust, on behalf of the Funds (except for the Alternative Strategies Allocation Fund and Global 130/30 Strategy Fund), and the Adviser (each an “Advisory Agreement” and together, the “Advisory Agreements”) were initially approved by the Board, including all of the Independent Trustees, at a Special Meeting held on July 10, 2007 and at the Board’s Quarterly Meeting held on August 27 and 28, 2007. Subsequently, the Advisory Agreements were approved by shareholders of the Funds (except for the Alternative Strategies Allocation Fund and Global 130/30 Strategy Fund) at Special Meetings held on October 4, 2007, November 1, 2007, December 20, 2007, January 31, 2008, and February 12, 2008. Subject to the terms and conditions provided for in the Advisory Agreements, each Advisory Agreement remains in effect for an initial two year term from the date of the Advisory Agreement and remains in effect for periods of one year thereafter subject to Board approval. Therefore, the continuation of the Advisory Agreements are next scheduled to be approved by the Board at the Trust’s August 2009 Meeting.